Influence of antiretroviral therapy characteristics on pediatric patient adherence;Influencia de las características del tratamiento antirretroviral en la adherencia del paciente pediátrico

Farmacia Hospitalaria

Volumn 28, Issue 6 SUPPL. 1, 2004, Pages 34-39

  Esteban Gomez M J ^a   Escobar Rodríguez, Ismael ^a   Vicario Zubizarreta, M J ^a   Clemente Pollan J ^a   Herreros De Tejada, A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Adherence; Antiretroviral therapy; Pediatrics

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CAREGIVER; CHILD; CLINICAL ARTICLE; DRUG FORMULATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; MALE; ODOR; PATIENT COMPLIANCE; PERCEPTION; PHARMACY; QUESTIONNAIRE; SCORING SYSTEM; SIDE EFFECT; TASTE; TREATMENT OUTCOME;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 14644401193     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. DHHS. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. September, 2003. http://hivatis.es.
2. a Edición). Barcelona: Ed. Permanyer, 2001.
3. Palumbo PE. Antirretroviral therapy of HIV infection. Pediatr Clin North Am 2000; 47: 155-69.
4. Watson DC, Farley JJ. Efficacy and adherence to highly active antirretroviral therapy (HAART) in children infected with human immunodeficiency virus type I. Pediatr Infect Dis J 1999; 18: 682-9.
5. Futterman D, Chabon B, Hoffman ND. HIV and AIDS in adolescents. Pediatr Clin North Am 2000; 47: 171-88.
6. Reddington C, Cohen J, Baldillo A, Toye M, Smith D, Kneut C, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J 2000; 19: 1148-53.
7. van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 2002; 109 (4): e61.
8. Pontali E, Feasi M, Toscanini F, Basetti M, de Gol P, Nuzzolese A, et al. Adherence to combination antiretroviral treatment in children. HIV Clin Trials 2001; 2 (6): 466-73.
9. Li LY, Stewart BH, Fleisher D. Oral delivery of HIV-protease inhibitors. Crit Rev Ther Drug Carrier Syst 2000; 17 (2): 73-99.